Background: Pain screening may improve the quality of care by identifying patients in need of further assessment and management. Many health care systems use the numeric rating scale (NRS) for pain screening, and record the score in the patients' electronic medical record (EMR).
P ain is one of the most common reasons for seeking medical care. 1 Pain screening may improve the quality of care by identifying patients in need of further assessment and management. 2, 3 One widely used screening instrument is the numeric rating scale (NRS) on which patients indicate their pain intensity on a scale of 0 (no pain) to 10 (worst pain). 4 The NRS is short, easy to administer, correlates with other measures of pain intensity, and is used in many large health care systems, including the Department of Veterans Affairs (VA). [5] [6] [7] Routine pain screening has been VA policy since 2003. 8 In the VA, patients are screened when vital signs are taken, and the NRS score is recorded in the electronic medical record (EMR). 8 Because it is a national, integrated system of care serving a diverse population of over 8 million patients in 152 medical centers and 800+ community-based outpatient clinics, 9 the VA's EMR-based NRS is a valuable resource because it can be readily analyzed, and, by merging with patient and facility characteristics, variation in pain reporting, course, treatment, temporal trends, and outcomes may be detected. 10 Although EMR-based NRS data is abundant, it has only recently been used in research. For example, 2 recent studies using such data found variation in pain reporting on the basis of sex. 11, 12 Several studies of EMR-based pain NRS have found underestimation compared with direct patient self-report.
In 1, one third of patients reporting pain-related functional interference on the Brief Pain Inventory had an NRS of 0 (ie, no pain) recorded. 13 Another study reported that a nurserecorded NRS correlated only "modestly" with a researcherrecorded NRS (r = 0.63) and that 51% of patients reported that nurse-recorded pain was rated qualitatively (eg, "how is your pain today?"), a practice associated with lower scores in the EMR. 14 However, it is unknown whether such discrepancies are associated with patient characteristics and potentially pain-related comorbid conditions, including depression, 15 substance use disorders, 16 posttraumatic stress disorder (PTSD), 17 human immunodeficiency virus (HIV), [18] [19] [20] and diabetes. 21 We compared a patient survey-based NRS to an EMRbased NRS collected on the same day during an outpatient visit. We examined the agreement, and, using the survey NRS as the gold standard, determined whether discrepancies between the 2 were associated with demographic and clinical characteristics, including the facility in which care was received.
METHODS

Participants
Data are from wave 3 of the Veterans Aging Cohort Study, an ongoing, prospective cohort study of HIV-infected patients, and an age-matched, race-matched, and sitematched comparison group of HIV-uninfected patients receiving care in 8 VA medical centers. 22, 23 HIV-infected participants were recruited from Infectious Diseases (ID) clinics, and comparators from General Medicine (GM) clinics. All participants gave written informed consent. More information is provided at http://www.vacohort.org.
Survey Information
All participants completed a self-administered paper survey, there were no proxy surveys. As recommended by VA clinical practice guidelines, a survey item asked the participant "On a scale of 0 to 10, where 0 means no pain and 10 means the worst possible pain, what is your current pain level?" Participants provided their age, sex, race/ethnicity, and height and weight (used to calculate body mass index). Those reporting Asian (n = 4), Pacific Islander (n = 4), Native American (n = 15), or multiple races (n = 34) were categorized as "other."
Administrative Data
We used VA administrative data to identify participants with an ID or GM outpatient visit (ie, stop codes 301, 323, or 310) on the survey day, verified by a blood pressure reading on that day. We then searched the EMR for an NRS score on that day. If there were >1, we retained the highest. Participants may have completed the survey either before or after their clinic visit, typically in the clinic waiting area. Diagnoses were on the basis of International Classification of Diseases, Ninth Revision codes from VA Patient Treatment Files. 24 Only chronic conditions noted in the prior year and up to 6 months after the survey were retained, as they were likely to be active at the time of the survey. We chose conditions on the basis of their high prevalence and potential relation to pain. Because opioid abuse may cause health care providers to "avoid full assessment of the pain complaint" 25 (p. 859, Ch 58 "Pain in HIV disease"), we determined whether the participant received any opioid medication in the year before the survey date.
Analysis
Because pain severity categories (eg, severe) have clinical applications, we categorized both scores into 4 levels: 0, no pain; 1-3, mild; 4-6, moderate; and Z7, severe. 26 As prior studies have demonstrated that EMR-based NRS underestimate direct patient reports of pain, we used the survey NRS as the gold standard, and defined a discrepancy as the survey NRS being Z4 (moderate to severe) but the EMR NRS being r3 (mild or no pain). This is consistent with VA's pain initiative, which states "it is reasonable to expect that a pain score of 4 or higher would trigger a comprehensive pain assessment and prompt intervention." 2, 27, 28 We used Spearman rank-order to assess correlation, the signed-rank test to determine the significance of the difference between the 2 NRS scores, and k to evaluate agreement on the 4 categories, and on any pain, moderate pain, and severe pain. 29 We report sensitivity and specificity of the EMR NRS for identifying any, mild, moderate, and severe pain in the survey. We calculated odds ratios for each characteristic, comparing the odds for a discrepancy for those with the characteristic to those without. We then used multivariable logistic regression to model the association of patient characteristics and facility with a discrepancy. In the results, facilities were assigned a letter to safeguard confidentiality. We used the Hosmer-Lemeshow test to assess model fit. 30 Analyses were performed using SAS 9.2 (SAS, Cary, NC).
RESULTS
A total of 4116 participants completed the survey, and 2346 (57%) had a clinic visit on the survey day. Among those with a visit, 1643 (70%) had an EMR NRS. Participants with a visit but without an EMR NRS had higher survey NRS scores compared with those with an EMR score (3.34 vs. 2.79, P < 0.001). Participants seen in ID were more likely to have an EMR NRS compared with those in GM (80% vs. 47%, P < 0.001). Women (40% vs. 71%), obese participants (62% vs. 72%), and those with alcohol use disorders (65% vs. 70%) were significantly less likely to have a have had an EMR NRS.
All 1643 participants with an EMR NRS had a survey NRS. Sociodemographic and clinical features of the sample are presented in Table 1 . Seventy percent of participants (n = 1152) had a 0 in the EMR, whereas 41% (n = 674) reported 0 on the survey NRS ( Fig. 1 ). The correlation between scores was 0.56 (95% confidence interval, 0.52-0.59), but the mean EMR was significantly lower than the survey NRS (1.72 vs. 2.79; P < 0.0001). Table 2 shows agreement between the 4 paincategories. The diagonal represents the number and percent of participants in the same category on both NRS (eg, among participants having no pain on the EMR NRS, 54.2% reported no pain on the survey). A total of 384 (23.4%) EMR NRS were categorized as moderate to severe pain (score of Z4), whereas in survey NRS it was 613 (37.3%). Overall agreement was 57.3% (942/1643). k was significant, but in the fair range (k = 0.35, 95% confidence interval, 0.32-0.38).
Agreement on any pain was fair (k = 0.35). The sensitivity, or proportion of participants with a survey NRS indicating any pain identified as such by the EMR, was low (0.46), but specificity was high (0.93). The positive predictive value, or proportion of participants identified by the EMRNRS as having any pain when the survey NRS indicated so, was high (0.90), but negative predictive value was poor (0.54). Agreement on mild pain was poor (k = 0.13), but moderate pain was higher (k = 0.36). For these categories, sensitivity was low, and specificity was high. Agreement on severe pain was good (k = 0.56). Both positive and negative predictive values were moderate to high (Table 3 ). Participants reporting other race (compared with white), with obesity, major depressive disorder (MDD), PTSD, drug use disorder, alcohol use disorders, diabetes, receiving opioids, receiving care in GM clinics, and those at facility B were more likely to report moderate to severe pain on the survey. Participants with PTSD had the highest prevalence of discrepancies (28.5%) ( Table 4) .
Seventeen percent (n = 284) of participants had a discrepancy in which the survey NRS was Z4 but the EMR was r3. In unadjusted analyses, participants aged 50 and older, those reporting other race (compared with white), with MDD, PTSD, alcohol use disorder, diabetes, or an opioid were each significantly more likely to have a discrepancy. Participants at facilities A, B, D, and F were more likely to have a discrepancy compared with H, the facility with the least discrepancies (11.1%). In the regression results, other race, MDD, PTSD, diabetes, and facility remained associated with increased odds of a discrepancy. Similar results were found when requiring a discrepancy of Z2 points, except that facility A was no longer different than H (data not shown).
DISCUSSION
We compared a pain NRS score entered in the EMR of a large health care system to a survey NRS score collected on the same day. We found that patients with high survey scores were more likely to have a missing EMR score, suggesting that these patients may be screened in a nonstandardized manner or that results are not entered in EMR numeric field. In particular, women, and those with obesity and alcohol disorders were less likely to have an EMR NRS. Despite a high correlation, the EMR NRS was significantly lower than the survey NRS, and discrepancies varied by patient characteristics and facility of care. Agreement on pain severity categories was moderate, and nearly half of participants who reported clinically actionable pain on the survey had a lower EMR score.
Because most screening in the VA is done by a health technician before the encounter, our findings are not consistent with "competing demands," whereby patients with multiple conditions receive less attention for each problem because of clinicians' time constraints. [31] [32] [33] Several studies reveal patients underreporting pain by race, sex, diagnoses, and age. [34] [35] [36] For example, Green and colleagues reports that "patients with cancer often do not want to be labeled as complainers, do not want to distract their physicians from treating the cancer, or are afraid that pain means that their cancer is progressing." In addition, Hispanic and African American patients reported concerns about pain treatment, in particular the potential for addiction. Our finding that patients with chronic conditions were more likely to have a discrepancy may be consistent with Green and colleague's; however, we did not find similar results for race.
Despite the VA being an integrated system of care, with a commitment to pain screening, we found a 2-fold difference in discrepancies by the facility. 37, 38 This may reflect differences in clinical documentation at these facilities. 39 For example, blood pressure is routinely collected and recorded in the EMR before the physician visit. If the reading is high, the physician may reassess it, entering the new reading in the progress note rather than the blood pressure field. 40 Facilities with a high staff turnover may experience more underreporting if patients are less likely to report pain to strangers. 41 Pain underestimation is also related to clinic staff using nonstandard screening methods. 14 Conversely, facilities with fewer discrepancies could have better pain screening practices as a result of staff and provider training, education, and monitoring, which are potentially transferable to poor performing sites.
Our findings have implications for the use of EMR NRS pain scores for clinical care and research. First, the EMR NRS may substantially underestimate the level of pain and result in undertreatment of clinically actionable pain if the provider relies on them to conduct further pain assessment. Second, because discrepancies vary by patient characteristics, the rate of pain treatment relative to the level of pain reported may seem to vary by condition. Third, as pain undertreatment may interfere with the treatment of other conditions, an important source of variation in outcomes may be unaccounted for. Fourth, because discrepancies vary by facility, statistically adjusting to reflect sources of variation is made more difficult.
Strengths of this study include data from a large integrated system of care with consistent information systems across facilities, surveys conducted on the visit day, data collection spanning a short duration reducing the potential for variation in screening policies and processes, and a large and diverse sample of patients. In addition, ours was a direct comparison of responses using the (hypothetically) same screening question in 2 different contexts.
Our study has several limitations. First, using the patients' pain report as the "gold standard" has been questioned in cases of cognitive impairment. 42, 43 Although we were unable to assess the participant's cognitive functioning, all were deemed eligible for participation by their providers. Second, there is no agreed-upon standard for clinically important pain, we chose a score of Z4 to be consistent with VA guidelines. Third, analysis was limited to patients seen in VA clinics most likely to administer a pain screen and thus we were unable to evaluate those seen in other clinics. Fourth, the Veterans Aging Cohort Study study focuses on patients with HIV and a matched comparison group. In our analysis, HIV status (and hence clinic) was not associated with a discrepancy, and we make no claims as to the prevalence of pain in these conditions, only the association between the 2 methods of pain reporting. Finally, our findings may be limited to primary care within the VA; thus, our results may not generalize to all care settings.
Our study reveals systematic underreporting of pain in the EMR compared with patient survey reported pain, and that discrepancies vary by chronic conditions such as PTSD and diabetes, and facility of care. As screening is useful only if it reflects the true condition of the patient, such discrepancies may diminish the clinical utility of the EMR NRS, and may lead to undertreatment or erroneous conclusions as to the success of treatment. Improving pain care may require better screening measures, possibly including direct patient entry of pain ratings. Although we did not examine the efficacy of patient data entry (eg, computer kiosks) in this study, such methods could help to reduce sources of variability in screening results associated with facility and rater effects, and patient socially desirable responses when interacting with health care staff. Our center is currently conducting a study in which we will compare cliniciandocumented versus patient-reported approaches directly in a multisite randomized controlled pain assessment trial, the Effective Screening for Pain Study.
